Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -2017/18 group results

May 11 (Reuters)- 
          Reprocell Incorporated 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2018    Mar 31, 2017    Mar 31, 2019      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales          926 mln          1.26            1.17                   
               (-26.4 pct)     (+18.0 pct)     (+26.1 pct)               
  Operating     loss 1.03     loss 944 mln    loss 757 mln               
  Recurring   loss 935 mln    loss 937 mln    loss 709 mln               
  Net
  Net           loss 2.17     loss 911 mln    loss 709 mln               
  EPS        loss 34.28 yen  loss 15.68 yen  loss 11.09 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Reprocell Incorporated.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news